Phenotype | SNP | Controls n (%) | Patients n (%) | OR (95% CI) | Uncorrected p | Corrected p |
---|---|---|---|---|---|---|
rs104893674 | < 0.001 | < 0.004 | ||||
CC | 37(37.4) | 0(0) | 1.09(0.66–0.97) | |||
ALL | AC | 64(62.6) | 94(89) | 1.57(1.37–1.85) | ||
AA | 0(0) | 7 (11) | 1 | < 0.001 | < 0.006 | |
C | 136(68) | 94(50) | 1.47(1.20–1.80) | |||
A | 62(32) | 94(50) | 2.19(1.44–3.32) | |||
rs104893674 | ||||||
CC | 14(9.9) | 1(1.3) | 1 | 0.027 | 0.031 | |
AML | AC | 79(84) | 91(97.1) | 0.6 (0.4–0.9) | ||
AA | 2(1.6) | 6(6.1) | 0.2(0.1–0.3) | |||
C | 95(47.5) | 91(45.5) | 1 | 0.068 | 0.074 | |
A | 105(52.5) | 109(54.5) | 0.9 (0.6–0.8) | |||
rs104893674 | ||||||
CC | 14(60.8) | 2(15.4) | 0.55(0.2–0.8) | |||
MPAL | AC | 6(26.1) | 9(57.7) | 0.84(0.4–1.2) | < 0.001 | < 0.003 |
AA | 3(13.1) | 4(26.9) | 0.46(0.15–0.3) | |||
C | 28(69.4) | 4(3.8) | 0.78(0.3–1.1) | < 0.001 | < 0.002 | |
A | 18(30.6) | 26(96.2) | 0.99(0.4–3.1) |